Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Commentary on: Dijkstra MG, van Zummeren M, Rozendaal L, et al. Safety of extending screening intervals beyond five years in cervical screening programmes with testing for high-risk human papillomavirus: 14-year follow-up of population-based randomised cohort in the Netherlands. BMJ 2016;355:i4924.
The cervical screening programmes in the UK and the Netherlands are replacing cytology by human papillomavirus (HPV) testing. In the Netherlands, women will be screened routinely at ages 30, 35, 40, 50 and 60 years. In the UK, a decision on screening frequency has yet to be made by the National Screening Committee. Currently British women are screened with cytology every 3 years at ages 25–49 and every 5 years at ages 50–64. Pooled results of four randomised controlled trials in Europe showed that HPV testing reduces cervical cancer risk.1 The British ARTISTIC trial2 and several other studies have also …
Competing interests None declared.
Provenance and peer review Commissioned; internally peer reviewed.